Stockreport

PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease [Yahoo! Finance]

PharmaCyte Biotech, Inc.  (PMCB) 
NASDAQ:AMEX Investor Relations: ir.pharmacytebiotech.com
PDF LAS VEGAS, May 21, 2024 BUSINESS WIRE )--PharmaCyte Biotech, Inc. (Nasdaq: PMCB) ("PharmaCyte" or the "Company"), today announced a $7 million investment in MyMD Pharma [Read more]